Lam Research Co. (NASDAQ:LRCX) Shares Bought by BSW Wealth Partners

BSW Wealth Partners grew its stake in Lam Research Co. (NASDAQ:LRCX) by 994.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 11,111 shares of the semiconductor company’s stock after acquiring an additional 10,096 shares during the period. BSW Wealth Partners’ holdings in Lam Research were worth $803,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the stock. Sunbelt Securities Inc. raised its position in shares of Lam Research by 3.9% during the 2nd quarter. Sunbelt Securities Inc. now owns 1,533 shares of the semiconductor company’s stock worth $1,633,000 after acquiring an additional 58 shares in the last quarter. Quarry LP increased its holdings in shares of Lam Research by 175.0% in the 2nd quarter. Quarry LP now owns 88 shares of the semiconductor company’s stock valued at $94,000 after acquiring an additional 56 shares during the period. Advisory Alpha LLC acquired a new position in Lam Research in the second quarter valued at $256,000. 3Chopt Investment Partners LLC acquired a new stake in shares of Lam Research during the second quarter worth about $1,105,000. Finally, Cetera Investment Advisers grew its holdings in shares of Lam Research by 2.1% during the second quarter. Cetera Investment Advisers now owns 28,382 shares of the semiconductor company’s stock worth $30,224,000 after buying an additional 585 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Barclays lowered their target price on Lam Research from $90.00 to $75.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Morgan Stanley raised their price objective on shares of Lam Research from $76.00 to $78.00 and gave the company an “equal weight” rating in a research report on Thursday, December 5th. BNP Paribas raised Lam Research to a “hold” rating in a research note on Thursday, October 24th. The Goldman Sachs Group decreased their price target on Lam Research from $96.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Finally, Sanford C. Bernstein cut their price objective on Lam Research from $95.00 to $85.00 and set a “market perform” rating for the company in a research report on Friday, November 29th. Nine equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, Lam Research has an average rating of “Moderate Buy” and an average price target of $95.77.

Lam Research Stock Down 1.5 %

LRCX opened at $74.51 on Wednesday. The business’s fifty day simple moving average is $75.53 and its 200 day simple moving average is $79.37. Lam Research Co. has a 52 week low of $68.87 and a 52 week high of $113.00. The firm has a market cap of $95.87 billion, a P/E ratio of 24.08, a PEG ratio of 1.53 and a beta of 1.45. The company has a quick ratio of 1.74, a current ratio of 2.53 and a debt-to-equity ratio of 0.53.

Lam Research Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Wednesday, December 11th were issued a dividend of $0.23 per share. The ex-dividend date of this dividend was Wednesday, December 11th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.23%. Lam Research’s dividend payout ratio (DPR) is presently 29.74%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.